We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
September has lived up to its reputation of a historically weak month for stocks. Despite the weakness, a few sectors have still been in green over the past month.
After a solid start to the third quarter, Wall Street lost momentum on fears of higher rates for a longer-than-expected period and a slowing Chinese economy.
In a significant development, the Department of Health and Human Services (HHS) has recently initiated a review of marijuana's classification under the Controlled Substances Act.
Marijuana stocks have been surging following a proposal by the Drug Enforcement Agency (???DEA???) to reclassify cannabis as a substance with reduced risk, fueling anticipation of federal legalization.
A fresh wave of investment opportunities emerges as the SAFE Banking Act is reintroduced to Congress, promising brighter prospects for marijuana stocks and ETFs.
Jazz (JAZZ) reports dismal fourth-quarter results as earnings and sales miss expectations. Sleep disorder drug Xywav become the company's largest product by net sales during the quarter.
While the rally has been broad based, the laggards of last year, like technology and communication services sectors as well as growth and small-cap stocks, have been outperforming this year.
Jazz's Q3 earnings and sales beat expectations on strong demand for new drugs and drugs added with the GW Pharmaceuticals acquisition. The company raises the mid-point of its 2022 sales guidance.
Innovative Industrial's (IIPR) Massachusetts property buyout and tie-up with a subsidiary of Curaleaf Holdings are expected to help this REIT enjoy solid opportunities in the company's markets.
JAZZ's Q2 earnings and sales beat expectations on strong demand for its new drugs and drugs added with the acquisition of GW Pharmaceuticals. The company affirms its 2022 guidance.
An expansion of the fund for a Danville property with Green Thumb Industries to help Innovative Industrial Properties (IIPR) benefit from favorable trends and boost its top line.
Innovative Industrial's (IIPR) Texas property buyout and tie-up with Texas Original are to help this REIT bank on solid opportunities in the company's markets and boost its top line.
marijuana: Archive
5 Sector ETFs That Survived the Market Downturn in September
by Sweta Killa
September has lived up to its reputation of a historically weak month for stocks. Despite the weakness, a few sectors have still been in green over the past month.
XMENegative Net Change PXJNegative Net Change KBWPNegative Net Change WEEDNegative Net Change URNJNegative Net Change
energy etfs insurance marijuana
Inside the Best-Performing ETF of Q3
by Sweta Killa
Roundhill Cannabis ETF (WEED) topped the list of the best-performing ETFs of the third quarter with impressive returns of about 49%.
GTBIFPositive Net Change CRLBFPositive Net Change WEEDNegative Net Change CURLFPositive Net Change
etfs marijuana
5 Best Leveraged-Inverse ETFs of September
by Sweta Killa
September is on track to be the worst month of the year.
LABDPositive Net Change DRVNegative Net Change HIBSNegative Net Change MSOXNegative Net Change JETDPositive Net Change
airlines biotechnology etfs marijuana real-estate
5 Sector ETFs That Beat the Market in Q3
by Sweta Killa
After a solid start to the third quarter, Wall Street lost momentum on fears of higher rates for a longer-than-expected period and a slowing Chinese economy.
XESNegative Net Change MLPONegative Net Change MSOSNegative Net Change URNJNegative Net Change EVXXPositive Net Change
electric-vehicles energy etfs marijuana
Behind the Recent Surge in Marijuana ETFs
by Sanghamitra Saha
In a significant development, the Department of Health and Human Services (HHS) has recently initiated a review of marijuana's classification under the Controlled Substances Act.
YOLONegative Net Change CNBSNegative Net Change MSOSNegative Net Change MJUSNegative Net Change WEEDNegative Net Change MSOXNegative Net Change
etfs marijuana
Cannabis ETFs Soar on Hopes of Federal Legalization
by Sweta Killa
Marijuana stocks have been surging following a proposal by the Drug Enforcement Agency (???DEA???) to reclassify cannabis as a substance with reduced risk, fueling anticipation of federal legalization.
YOLONegative Net Change CNBSNegative Net Change MSOSNegative Net Change MJUSNegative Net Change WEEDNegative Net Change
etfs marijuana
Cannabis ETFs Surge on Legalization Hopes: More Run Ahead?
by Sanghamitra Saha
The prospect of marijuana reclassification has injected newfound optimism into the cannabis investment landscape.
MJNegative Net Change YOLONegative Net Change POTXPositive Net Change MSOSNegative Net Change MJUSNegative Net Change
etfs marijuana
SAFE Banking Act Resurgence Boosts Pot ETFs: A New Era Ahead?
by Sanghamitra Saha
A fresh wave of investment opportunities emerges as the SAFE Banking Act is reintroduced to Congress, promising brighter prospects for marijuana stocks and ETFs.
MJNegative Net Change YOLONegative Net Change CNBSNegative Net Change MSOSNegative Net Change MJUSNegative Net Change
etfs marijuana
Is Tilray Brands (TLRY) A Buy Ahead of Fiscal Q3 Earnings Announcement?
by Bryan Hayes
Industry headwinds still present a major challenge.
TLRYPositive Net Change
cannabis earnings investing marijuana meme-stocks pot-stocks
Jazz's (JAZZ) Q4 Earnings Miss Estimates, New Drugs Drive Sales
by Zacks Equity Research
Jazz (JAZZ) reports dismal fourth-quarter results as earnings and sales miss expectations. Sleep disorder drug Xywav become the company's largest product by net sales during the quarter.
JAZZNegative Net Change AMRNPositive Net Change AXSMNegative Net Change ALLONegative Net Change
cannabis earnings marijuana medical
ETF Laggards of 2022 That Are Leading This Year
by Sweta Killa
While the rally has been broad based, the laggards of last year, like technology and communication services sectors as well as growth and small-cap stocks, have been outperforming this year.
ARKKPositive Net Change JSMLNegative Net Change XLCNegative Net Change MEMEPositive Net Change WGMINegative Net Change
bitcoin communications etfs marijuana tech-stocks
Top and Flop ETFs of 2022
by Sweta Killa
We have highlighted three ETFs, each from the best and worst-performing zones of 2022.
OIHNegative Net Change TURPositive Net Change BDRYPositive Net Change PFIXPositive Net Change
energy etfs marijuana tech-stocks
Jazz's (JAZZ) Q3 Earnings Beat Estimates, New Drugs Drive Sales
by Zacks Equity Research
Jazz's Q3 earnings and sales beat expectations on strong demand for new drugs and drugs added with the GW Pharmaceuticals acquisition. The company raises the mid-point of its 2022 sales guidance.
GILDNegative Net Change VRTXNegative Net Change JAZZNegative Net Change
marijuana
Is Tilray Brands (TLRY) A 'Buy' After Q1 Earnings Announcement?
by Bryan Hayes
President Biden recently initiated an official review of how marijuana is scheduled under federal law.
TLRYPositive Net Change
earnings investing marijuana retail stock-performance
Cannabis ETFs Trending Up to Start Q4
by Sweta Killa
Cannabis stocks and ETFs gained momentum to start the fourth quarter thanks to President Joe's announcement of a historic marijuana reform.
YOLONegative Net Change CNBSNegative Net Change MSOSNegative Net Change MJUSNegative Net Change WEEDNegative Net Change
etfs marijuana
Top and Flop ETFs of Nine Months of 2022
by Sweta Killa
We have highlighted the three ETFs each from the best and worst-performing zones of the nine months of 2022.
UNGNegative Net Change BDRYPositive Net Change YOLONegative Net Change KMLMNegative Net Change DAPPNegative Net Change PFIXPositive Net Change
energy etfs marijuana tech-stocks
Innovative Industrial (IIPR) Cheers Investors With Dividend Hike
by Zacks Equity Research
Innovative Industrial's (IIPR) 2.9% sequential dividend hike reflects its business strength and focus on increasing shareholders' wealth.
PLDPositive Net Change EXRPositive Net Change IIPRPositive Net Change
finance marijuana reit
Innovative Industrial (IIPR) Expands With Massachusetts Asset
by Zacks Equity Research
Innovative Industrial's (IIPR) Massachusetts property buyout and tie-up with a subsidiary of Curaleaf Holdings are expected to help this REIT enjoy solid opportunities in the company's markets.
HSTNegative Net Change EXRPositive Net Change IIPRPositive Net Change
marijuana reit
5 Top-Performing Sector ETFs of August
by Sweta Killa
The month of August was marked by ups and downs.
IEONegative Net Change MLPONegative Net Change URNMNegative Net Change MJUSNegative Net Change PSILNegative Net Change
energy etfs marijuana
Jazz's (JAZZ) Q2 Earnings Beat, New Drugs Post Robust Sales
by Zacks Equity Research
JAZZ's Q2 earnings and sales beat expectations on strong demand for its new drugs and drugs added with the acquisition of GW Pharmaceuticals. The company affirms its 2022 guidance.
LLYNegative Net Change JAZZNegative Net Change NVAXPositive Net Change AXSMNegative Net Change
cannabis marijuana
Innovative Industrial (IIPR) Ups Funding for Danville Asset
by Zacks Equity Research
An expansion of the fund for a Danville property with Green Thumb Industries to help Innovative Industrial Properties (IIPR) benefit from favorable trends and boost its top line.
EXRPositive Net Change OUTPositive Net Change IIPRPositive Net Change
finance marijuana reit
Innovative Industrial (IIPR) Expands With Texas Property Buyout
by Zacks Equity Research
Innovative Industrial's (IIPR) Texas property buyout and tie-up with Texas Original are to help this REIT bank on solid opportunities in the company's markets and boost its top line.
PLDPositive Net Change OUTPositive Net Change IIPRPositive Net Change
finance marijuana reit
Roundhill's Cannabis ETF (WEED) Launch Seems Timely
by Sanghamitra Saha
Roundhill Investments recently announced the launch of its own cannabis ETF, namely Roundhill Cannabis ETF (WEED).
MJNegative Net Change YOLONegative Net Change TOKENegative Net Change MSOSNegative Net Change WEEDNegative Net Change
etfs marijuana
Cannabis ETFs Set to Soar on Passage of Legalization Bill
by Sweta Killa
Cannabis stocks are poised to surge further especially following the legislation passed by the House to legalize marijuana nationwide.
MJNegative Net Change YOLONegative Net Change THCXNegative Net Change CNBSNegative Net Change POTXPositive Net Change
etfs marijuana
Cannabis ETFs Soar Last Week
by Sweta Killa
Cannabis ETFs have topped the list of best performing ETFs last week on hopes of federal legalization vote.
MJNegative Net Change THCXNegative Net Change POTXPositive Net Change
etfs marijuana